M6A修饰调节了瘤抑制剂DIRAS1在子宫癌细胞中的表达
Yu-Yan Wang1, Lian-Hua Ye2, An-Qi Zhao3
1Department of Obstetrics and Gynecology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, China.
Cancer biology & therapy
|February 19, 2024
概括
在宫癌中,DIRAS1作为瘤抑制剂,在瘤中显著减少其表达. 它的调节涉及m6A修饰,影响癌细胞增殖和转移.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 迪拉斯家族GTPase 1 (DIRAS1) 是一种潜在的瘤抑制剂.
- 它在宫癌中的作用和表达尚未得到充分理解.
研究的目的:
- 研究DIRAS1在宫癌中的表达模式和功能.
- 探索DIRAS1的调节机制,包括表观遗传修饰.
主要方法:
- 在C33A和SiHa细胞中,DIRAS1被淘汰和过度表达.
- 在宫癌组织中分析DIRAS1mRNA和蛋白质水平.
- 使用表观遗传抑制剂 (5-阿扎丁,SAHA) 和FTO抑制剂 (FB23-2) 的治疗.
- 对m6A修饰酶 (METTL3,METTL14,FTO,ALKBH5) 的研究.
主要成果:
- 抑制DIRAS1促进了宫癌细胞的增殖,迁移和入侵.
- DIRAS1过度表达抑制了细胞活力和运动.
- 在宫癌组织中,DIRAS1 mRNA和蛋白质水平明显较低.
- DIRAS1表达与病理等级负相关.
- 表观遗传抑制剂影响了DIRAS1mRNA,但没有影响蛋白质水平.
- m6A修饰酶对DIRAS1mRNA和蛋白质水平进行了差异调节.
结论:
- 在宫癌中,DIRAS1表现出显著的抗瘤活性.
- 在宫癌中,DIRAS1的表达下调,这可能是由于m6A的修饰.
- 在宫癌中,m6A修饰在调节DIRAS1mRNA稳定性和蛋白质翻译方面发挥着至关重要的作用.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
Small GTPases - Ras and Rho
4.0K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
4.0K
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


